206 related articles for article (PubMed ID: 34412918)
1. Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment.
Lodi RS; Yu B; Xia L; Liu F
Hum Immunol; 2021 Dec; 82(12):937-944. PubMed ID: 34412918
[TBL] [Abstract][Full Text] [Related]
2. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
3. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
7. NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development.
Ratnam NM; Peterson JM; Talbert EE; Ladner KJ; Rajasekera PV; Schmidt CR; Dillhoff ME; Swanson BJ; Haverick E; Kladney RD; Williams TM; Leone GW; Wang DJ; Guttridge DC
J Clin Invest; 2017 Oct; 127(10):3796-3809. PubMed ID: 28891811
[TBL] [Abstract][Full Text] [Related]
8. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Wischhusen J; Melero I; Fridman WH
Front Immunol; 2020; 11():951. PubMed ID: 32508832
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
An Y; Liu F; Chen Y; Yang Q
J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
[TBL] [Abstract][Full Text] [Related]
10. The clinical role of the TME in solid cancer.
Giraldo NA; Sanchez-Salas R; Peske JD; Vano Y; Becht E; Petitprez F; Validire P; Ingels A; Cathelineau X; Fridman WH; Sautès-Fridman C
Br J Cancer; 2019 Jan; 120(1):45-53. PubMed ID: 30413828
[TBL] [Abstract][Full Text] [Related]
11. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
12. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.
de Looff M; de Jong S; Kruyt FAE
Front Immunol; 2019; 10():1530. PubMed ID: 31333662
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints.
Baghbani E; Noorolyai S; Shanehbandi D; Mokhtarzadeh A; Aghebati-Maleki L; Shahgoli VK; Brunetti O; Rahmani S; Shadbad MA; Baghbanzadeh A; Silvestris N; Baradaran B
Life Sci; 2021 Oct; 282():119826. PubMed ID: 34265363
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding the immune microenvironment in ovarian cancer.
Chen J; Yang L; Ma Y; Zhang Y
Front Immunol; 2024; 15():1412328. PubMed ID: 38903506
[TBL] [Abstract][Full Text] [Related]
15. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
[TBL] [Abstract][Full Text] [Related]
17. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.
Laplagne C; Domagala M; Le Naour A; Quemerais C; Hamel D; Fournié JJ; Couderc B; Bousquet C; Ferrand A; Poupot M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547627
[TBL] [Abstract][Full Text] [Related]
18. GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme.
Hasanpour Segherlou Z; Nouri-Vaskeh M; Noroozi Guilandehi S; Baghbanzadeh A; Zand R; Baradaran B; Zarei M
J Cell Physiol; 2021 Aug; 236(8):5564-5581. PubMed ID: 33580506
[TBL] [Abstract][Full Text] [Related]
19. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
Laha D; Grant R; Mishra P; Nilubol N
Front Immunol; 2021; 12():656908. PubMed ID: 33986746
[TBL] [Abstract][Full Text] [Related]
20. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
